These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Bennett AM; Lescott T; Phillpotts RJ Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402 [TBL] [Abstract][Full Text] [Related]
12. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
13. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. Mathews JH; Roehrig JT; Trent DW J Virol; 1985 Sep; 55(3):594-600. PubMed ID: 2410632 [TBL] [Abstract][Full Text] [Related]
14. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. Elvin SJ; Bennett AM; Phillpotts RJ J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032 [TBL] [Abstract][Full Text] [Related]
15. Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses. Hunt AR; Roehrig JT Vaccine; 1995 Feb; 13(3):281-8. PubMed ID: 7543231 [TBL] [Abstract][Full Text] [Related]
16. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359 [TBL] [Abstract][Full Text] [Related]